Abstract
Background
Although the efficacy of various biologic meshes in the abdominal reconstruction of complex ventral hernia has been shown, the performance profile of various biologic mesh scaffolds in terms of hernia-specific outcomes such as recurrence, mesh explantation, and mesh infections has not been examined.
Aim
To evaluate the clinical outcomes of patients who underwent complex ventral hernia repair with bioprosthetic material.
Methods
This study is a retrospective analysis of the use of bioprosthetic material in complex ventral hernia at an academic institution from January 2002 to December 2007.
Results
A total of 58 patients with a mean age of 57.2 years and mean body mass index (BMI) of 33.8 who underwent reconstruction of ventral abdominal defects with a bioprosthetic from January 2002 to February 2009 were included in the study. The study patients had about 4.8 previous surgeries and 43.1% of patients had reconstruction in a setting of enterocutaneous fistula, while 46.6% had a previous mesh infection. Complex ventral hernia was seen in 50 patients, while eight patients had ventral and parastomal hernia. The type of biologic used for reconstruction was human-derived (AlloDerm, 29), porcine cross-linked (CollaMend, 3; Permacol, 2), and non-cross-linked porcine (Surgisis, 16; Strattice, 8). At least one complication was seen in 72.4% of patients. Major complications noted were surgical wound infections (19.0%), seroma (8.6%), and abscess formation (5.2%). The one-year hernia recurrence rate was 27.9% and mesh explantation was needed in 17.2% of patients. AlloDerm was less likely to be explanted (13.8%) or become infected (37.9%) but more likely to recur (28.6%) compared to porcine cross-linked bioprosthesis. Porcine cross-linked biologics were more likely to become infected (60%) and explanted (40%) but less likely to recur (20%) compared to AlloDerm. Non-cross-linked porcine biologics were less likely to be explanted (16.7%) but had higher recurrence (29.4%) compared to cross-linked porcine biologics and a higher infection rate (54.2%) compared to AlloDerm.
Conclusions
The results from this study underscore the difficulty of repairing complex abdominal wall defects in contaminated fields. Cross-linked porcine biologics showed relatively higher infection and explantation rates. Equivalent recurrence and explantation rates were observed for the non-cross-linked porcine biologics and AlloDerm. These data indicate that there is currently no ideal biologic for complex ventral hernia repair.
Similar content being viewed by others
Abbreviations
- IRB:
-
Institutional review board
- SD:
-
Standard deviation
- BMI:
-
Body mass index
References
Anthony T, Bergen PC, Kim LT, Henderson M, Fahey T, Rege RV, Turnage RH (2000) Factors affecting recurrence following incisional herniorrhaphy. World J Surg 24:95–100; discussion 101
Luijendijk RW, Hop WC, van den Tol MP, de Lange DC, Braaksma MM, IJzermans JN, Boelhouwer RU, de Vries BC, Salu MK, Wereldsma JC, Bruijninckx CM, Jeekel J (2000) A comparison of suture repair with mesh repair for incisional hernia. N Engl J Med 343:392–398
Sauerland S, Schmedt CG, Lein S, Leibl BJ, Bittner R (2005) Primary incisional hernia repair with or without polypropylene mesh: a report on 384 patients with 5-year follow-up. Langenbecks Arch Surg 390:408–412
Basoglu M, Yildirgan MI, Yilmaz I, Balik A, Celebi F, Atamanalp SS, Polat KY, Oren D (2004) Late complications of incisional hernias following prosthetic mesh repair. Acta Chir Belg 104:425–428
Deligiannidis N, Papavasiliou I, Sapalidis K, Kesisoglou I, Papavramidis S, Gamvros O (2002) The use of three different mesh materials in the treatment of abdominal wall defects. Hernia 6:51–55
Diaz JJ Jr, Gray BW, Dobson JM, Grogan EL, May AK, Miller R, Guy J, O’Neill P, Morris JA Jr (2004) Repair of giant abdominal hernias: does the type of prosthesis matter? Am Surg 70:396–401; discussion 401–2
Leber GE, Garb JL, Alexander AI, Reed WP (1998) Long-term complications associated with prosthetic repair of incisional hernias. Arch Surg 133:378–382
Diaz JJ Jr, Conquest AM, Ferzoco SJ, Vargo D, Miller P, Wu YC, Donahue R (2009) Multi-institutional experience using human acellular dermal matrix for ventral hernia repair in a compromised surgical field. Arch Surg 144:209–215
Fabian TC, Croce MA, Pritchard FE, Minard G, Hickerson WL, Howell RL, Schurr MJ, Kudsk KA (1994) Planned ventral hernia. Staged management for acute abdominal wall defects. Ann Surg 219:643–650; discussion 651–3
Jernigan TW, Fabian TC, Croce MA, Moore N, Pritchard FE, Minard G, Bee TK (2003) Staged management of giant abdominal wall defects: acute and long-term results. Ann Surg 238:349–355; discussion 355–7
Rosen MJ, Jin J, McGee MF, Williams C, Marks J, Ponsky JL (2007) Laparoscopic component separation in the single-stage treatment of infected abdominal wall prosthetic removal. Hernia 11:435–440
Kuo YR, Kuo MH, Lutz BS, Huang YC, Liu YT, Wu SC, Hsieh KC, Hsien CH, Jeng SF (2004) One-stage reconstruction of large midline abdominal wall defects using a composite free anterolateral thigh flap with vascularized fascia lata. Ann Surg 239:352–358
Mathes SJ, Steinwald PM, Foster RD, Hoffman WY, Anthony JP (2000) Complex abdominal wall reconstruction: a comparison of flap and mesh closure. Ann Surg 232:586–596
DeFranzo AJ, Kingman GJ, Sterchi JM, Marks MW, Thorne MT (1996) Rectus turnover flaps for the reconstruction of large midline abdominal wall defects. Ann Plast Surg 37:18–23
Matthews MS (1999) Abdominal wall reconstruction with an expanded rectus femoris flap. Plast Reconstr Surg 104:183–186
Paton BL, Novitsky YW, Zerey M, Sing RF, Kercher KW, Heniford BT (2007) Management of infections of polytetrafluoroethylene-based mesh. Surg Infect (Larchmt) 8:337–341
Chew DK, Choi LH, Rogers AM (2000) Enterocutaneous fistula 14 years after prosthetic mesh repair of a ventral incisional hernia: a life-long risk? Surgery 127:352–353
Halm JA, de Wall LL, Steyerberg EW, Jeekel J, Lange JF (2007) Intraperitoneal polypropylene mesh hernia repair complicates subsequent abdominal surgery. World J Surg 31:423–429; discussion 430
Hiles M, Record Ritchie RD, Altizer AM (2009) Are biologic grafts effective for hernia repair?: a systematic review of the literature. Surg Innov 16:26–37
Bachman S, Ramshaw B (2008) Prosthetic material in ventral hernia repair: how do I choose? Surg Clin North Am 88:101–112
Catena F, Ansaloni L, Gazzotti F, Gagliardi S, Di Saverio S, D’Alessandro L, Pinna AD (2007) Use of porcine dermal collagen graft (Permacol) for hernia repair in contaminated fields. Hernia 11:57–60
Chavarriaga LF, Lin E, Losken A, Cook MW, Jeansonne LO, White BC, Sweeney JF, Galloway JR, Davis SS Jr (2010) Management of complex abdominal wall defects using acellular porcine dermal collagen. Am Surg 76:96–100
Cobb GA, Shaffer J (2005) Cross-linked acellular porcine dermal collagen implant in laparoscopic ventral hernia repair: case-controlled study of operative variables and early complications. Int Surg 90:S24–S29
Helton WS, Fisichella PM, Berger R, Horgan S, Espat NJ, Abcarian H (2005) Short-term outcomes with small intestinal submucosa for ventral abdominal hernia. Arch Surg 140:549–560; discussion 560–2
Lin HJ, Spoerke N, Deveney C, Martindale R (2009) Reconstruction of complex abdominal wall hernias using acellular human dermal matrix: a single institution experience. Am J Surg 197:599–603; discussion 603
Pomahac B, Aflaki P (2010) Use of a non-cross-linked porcine dermal scaffold in abdominal wall reconstruction. Am J Surg 199:22–27
Diaz JJ Jr, Guy J, Berkes MB, Guillamondegui O, Miller RS (2006) Acellular dermal allograft for ventral hernia repair in the compromised surgical field. Am Surg 72:1181–1187; discussion 1187–8
Schuster R, Singh J, Safadi BY, Wren SM (2006) The use of acellular dermal matrix for contaminated abdominal wall defects: wound status predicts success. Am J Surg 192:594–597
Blatnik J, Jin J, Rosen M (2008) Abdominal hernia repair with bridging acellular dermal matrix—an expensive hernia sac. Am J Surg 196:47–50
Jin J, Rosen MJ, Blatnik J, McGee MF, Williams CP, Marks J, Ponsky J (2007) Use of acellular dermal matrix for complicated ventral hernia repair: does technique affect outcomes? J Am Coll Surg 205:654–660
de Vries Reilingh TS, van Goor H, Rosman C, Bemelmans MH, de Jong D, van Nieuwenhoven EJ, van Engeland MI, Bleichrodt RP (2003) “Components separation technique” for the repair of large abdominal wall hernias. J Am Coll Surg 196:32–37
Kolker AR, Brown DJ, Redstone JS, Scarpinato VM, Wallack MK (2005) Multilayer reconstruction of abdominal wall defects with acellular dermal allograft (AlloDerm) and component separation. Ann Plast Surg 55:36–41; discussion 41–2
den Hartog D, Dur AH, Tuinebreijer WE, Kreis RW (2008) Open surgical procedures for incisional hernias. Cochrane Database Syst Rev (3):CD006438
Iqbal CW, Pham TH, Joseph A, Mai J, Thompson GB, Sarr MG (2007) Long-term outcome of 254 complex incisional hernia repairs using the modified Rives–Stoppa technique. World J Surg 31:2398–2404
Liyanage SH, Purohit GS, Frye JN, Giordano P (2006) Anterior abdominal wall reconstruction with a Permacol implant. J Plast Reconstr Aesthet Surg 59:553–555
Harth KC, Rosen MJ (2009) Major complications associated with xenograft biologic mesh implantation in abdominal wall reconstruction. Surg Innov 16:324–329
Shaikh FM, Giri SK, Durrani S, Waldron D, Grace PA (2007) Experience with porcine acellular dermal collagen implant in one-stage tension-free reconstruction of acute and chronic abdominal wall defects. World J Surg 31:1966–1972; discussion 1973–4, 1975
Ueno T, Pickett LC, de la Fuente SG, Lawson DC, Pappas TN (2004) Clinical application of porcine small intestinal submucosa in the management of infected or potentially contaminated abdominal defects. J Gastrointest Surg 8:109–112
Candage R, Jones K, Luchette FA, Sinacore JM, Vandevender D, Reed RL 2nd (2008) Use of human acellular dermal matrix for hernia repair: friend or foe? Surgery 144:703–709; discussion 709–1
Lee EI, Chike-Obi CJ, Gonzalez P, Garza R, Leong M, Subramanian A, Bullocks J, Awad SS (2009) Abdominal wall repair using human acellular dermal matrix: a follow-up study. Am J Surg 198:650–657
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shah, B.C., Tiwari, M.M., Goede, M.R. et al. Not all biologics are equal!. Hernia 15, 165–171 (2011). https://doi.org/10.1007/s10029-010-0768-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10029-010-0768-7